Evaluation of C-Reactive Protein Before and On-Treatment as a Predictor of Benefit of Atorvastatin: A Cohort Analysis From the Anglo-Scandinavian Cardiac Outcomes Trial Lipid Lowering Arm

Study Questions:

Does baseline and/or on-statin C-reactive protein (CRP) predict cardiovascular (CV) outcome beyond low-density lipoprotein cholesterol (LDL-C)?